✦ LIBER ✦

Trypanosoma cruzi: Studies on the reactivity of antibodies bound to the surface of blood forms at the early phase of infection

✍ Scribed by Elizabeth N. De Gaspari; Anna Maria S. Stolf; Eufrosina S. Umezawa; Bianca Zingales; Ises A. Abrahamsohn

Book ID: 115649378
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 962 KB
Volume: 56
Category: Article
ISSN: 0001-706X
DOI: 10.1016/0001-706x(94)90042-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trypanosoma cruzi: Correlation of resist

Trypanosoma cruzi: Correlation of resistance and susceptibility in infected inbred mice with the in vivo primary antibody response to sheep red blood cells

✍ Herbert B. Tanowitz; Nagahiro Minato; Richard Lalonde; Murray Wittner 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 785 KB

Preliminary Studies by ELISA on the Anti

Preliminary Studies by ELISA on the Antigen and Antibody Dynamics in the Early Stages of Experimental Infections with Trypanosoma evansi in Cattle

✍ S. Thammasart; R. Kanitpun; M. Saithasao; Y. Kashiwazaki 📂 Article 📅 2001 🏛 Springer Netherlands 🌐 English ⚖ 128 KB

Long-term follow-up studies on herpes si

Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of herpes simplex virus infected cells

✍ Brith Christenson; Åke Espmark 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 598 KB

## Abstract In a serological follow‐up of 88 women with active invasive cervical carcinoma, antibodies to membrane antigen of Herpes simplex virus (HSV)‐ infected cells were measured by the use of the mixed hemadsorption method. Sera were collected at the time of initial treatment and then at regul

A randomized double-blind, placebo-contr

A randomized double-blind, placebo-controlled study to assess the effects of omalizumab (humanized monoclonal anti-IgE antibody) on the early- and late-phase skin reactions and cellular infiltrate after multiple intradermal allergen challenges*1

✍ ONG, Y 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 25 KB

86 A phase I/II open-label study to asse

86 A phase I/II open-label study to assess the safety, pharmacokinetic profile, and preliminary antiviral effects of ost-577 (a human anti-hepatitis b surface antigen monoclonal antibody) administered to patients who are persistently hepatitis b antigen seropositive: DP Paar, MD, BM Montgomerie, RN, P Nadler, MD, ER Schiff, MD and RB Pollard, MD. The University of Texas Medical Branch at Galveston, Galveston, TX, USA; Protein Design Labs, Mountain View, CA, USA; the University of Miami, Miami, FL, USA

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 76 KB